Pictured above is Martin Shkreli, 32, founder and chief executive of Turing Pharmaceuticals who was a former hedge fund manager, purchased the rights to Daraprim –
Daraprim a drug which is used to treat life-threatening parasitic infections which costs roughly $1 to produce, was increased to $750 per tablet. The drug cost only $13.50 per tablet and you needed only 100 tablets to treat yourself and be well.
Shkreli told Bloomberg that Daraprim had been priced too low and that his company needed to generate profits that it would spend on new research and development.
‘This isn’t the greedy drug company trying to gouge patients, it is us trying to stay in business,’ Shkreli said.
He added that many patients use the drug for less than a year and that the price is on par with drugs similar that are used to treat rare diseases.
People reacted to the increase in price via social media! including US Presidential aspirant, Hilary Clinton, but Shkreli has backed the decision. He had an OK Cupid account which he has since deleted.
see reactions below…